West Pharmaceutical-West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend

Conference Call Scheduled for 9 a.m. EDT Today -EXTON, Pa., Oct. 24, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2024 and declared a fourth-quarter 2024 dividend.Third-Quarter 2024 Summary (comparisons to prior-year period)Net sales of $746.9 million declined 0.1%; organic net sales decline was 0.5%.Reported-diluted EPS of$ 1.85, compared to $2.14 in the same period last year.Adjusted-diluted EPS of$ 1.85, compared to $2.1 ...